
NeuroOne Medical Technologies Corporation
NMTC institutional ownership changes in Q2 2026: 14 institutions opened or added positions, 0 trimmed or exited. NMTC (NeuroOne Medical Technologies Corporation) is held by 14 institutional investors as of Q2 2026. Top institutional shareholders: Vanguard Capital Management LLC ($1.1M), Geode Capital Management, LLC ($284,446), Renaissance Technologies LLC ($215,417). Net institutional sentiment: Bullish.
Who's Trading
Latest move
Source dates: Price Nov 3, 2026 · Insiders Sep 8, 2026 · Activists Nov 12, 2025 · Congress none
Top Holders
Showing 1-20 of 20
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about NMTC
Who owns NMTC?
14 institutional investors held NMTC on June 30, 2026, led by Vanguard Capital Management LLC ($1.1M), Geode Capital Management, LLC ($284,446) and Renaissance Technologies LLC ($215,417).
How many hedge funds hold NMTC?
14 institutional investors reported NMTC in their 13F filings for the quarter ended June 30, 2026, $2M in all. One of them is rated Elite.
Are institutions buying or selling NMTC?
Buying, on balance. In Q2 2026, 14 institutions opened or added to positions in NMTC and 0 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer